We are live on
!
Find out more
FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
1-Year Est. Return
44.84%
This Fund
S&P 500
This Quarter
Est. Return
+27.95%
1 Year Est. Return
+44.84%
3 Year Est. Return
-66.21%
5 Year Est. Return
-36.36%
10 Year Est. Return
–
AUM
$49.5M
AUM Growth
-$435K
(-0.87%)
Cap. Flow
-$12.9M
Cap. Flow
% of AUM
-26.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$12.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
AG
SAM
AC
QI
TAAM
NAM
MSKCC
BRC
Foresite Capital Management II's Q4 2022 Portfolio in Review
As of Q4 2022, Foresite Capital Management II held 1 position worth $49.5M, down 0.87% from $49.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Foresite Capital Management II withdrew a net $12.9M in Q4 2022, reducing 1 holding. Its largest reduction was 10x Genomics, cutting an estimated $12.9M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Foresite Capital Management II's biggest Q4 2022 reduction was 10x Genomics, cutting an estimated $12.9M.
- Foresite Capital Management II's ten largest holdings make up 100% of its $49.5M portfolio in Q4 2022.
- Foresite Capital Management II opened 0 new positions and closed 0 in Q4 2022.
- Foresite Capital Management II's portfolio value fell 0.87% quarter-over-quarter to $49.5M.
Based on Foresite Capital Management II's 13F filing for Q4 2022, filed 13 Feb 2023.